The short version
- In 5,448 MESA participants, high total calcium intake was associated with lower risk of developing coronary artery calcification (relative risk 0.73), but after adjusting for total intake, supplement use specifically was associated with increased risk (relative risk 1.22, 95% CI 1.07 to 1.39).
- A meta-analysis of randomised trials of calcium supplements without vitamin D found 143 myocardial infarctions on calcium versus 111 on placebo among 8,151 participants, hazard ratio 1.31 (95% CI 1.02 to 1.67).
- Across 26 randomised trials, calcium supplements reduced total fracture risk by 11% but showed no significant effect on hip or forearm fracture, and in the four trials at lowest risk of bias there was no effect at any site.
- In the Women's Health Initiative, calcium plus vitamin D raised hip bone density 1.06%, did not significantly reduce hip fracture, and increased kidney stone risk with a hazard ratio of 1.17.
- The one trial showing a clear fracture reduction was in frail elderly women in residential care with low dietary calcium and low vitamin D, not in generally healthy adults.
Calcium supplementation is one of the most routinely recommended interventions for women after menopause, and one of the least examined by the people taking it. The assumption underneath it is that calcium is calcium — that a tablet is just a convenient dairy substitute. The data does not support that assumption, and the divergence is the point of this article.
The same nutrient, two different results
The Multi-Ethnic Study of Atherosclerosis followed 5,448 adults aged 45 to 84 who were free of clinically diagnosed cardiovascular disease, measuring calcium intake from food and from supplements separately and scanning for coronary artery calcification, with repeat scans in 2,742 people about ten years later.
Among 1,567 participants with no calcification at baseline, high total calcium intake was associated with a lower risk of developing it — relative risk 0.73 (95% CI 0.57 to 0.93) in the top intake quintile versus the bottom. Then the authors adjusted for total intake and looked at supplement use on its own. Supplement use was associated with an increased risk of incident calcification, relative risk 1.22 (95% CI 1.07 to 1.39).
Same nutrient, same total amount, opposite direction depending on delivery. This is observational and cannot establish cause, and the authors said as much. But it is the clearest illustration available of why the food-versus-pill distinction is not pedantry.
The cardiovascular signal from the randomised data
A patient-level and trial-level meta-analysis pooled randomised placebo-controlled trials of calcium supplements at 500mg a day or more, lasting over a year, in participants averaging over 40. In the five studies with patient-level data (8,151 participants, median follow-up 3.6 years), 143 people on calcium had a myocardial infarction versus 111 on placebo — hazard ratio 1.31 (95% CI 1.02 to 1.67, P = 0.035). The trial-level analysis of 11,921 participants gave a pooled relative risk of 1.27 (1.01 to 1.59, P = 0.038).
Stroke did not reach significance (1.20, 0.96 to 1.50). Neither did the composite endpoint (1.18, 1.00 to 1.39) or death (1.09, 0.96 to 1.23). These trials tested calcium without co-administered vitamin D, and the finding has been argued about for fifteen years. It has not been withdrawn.
And what was the benefit supposed to be?
Thinner than the recommendation implies. A systematic review of calcium intake and fracture found that in 26 randomised trials, calcium supplements reduced total fracture risk (relative risk 0.89, 95% CI 0.81 to 0.96) and vertebral fracture (0.86, 0.74 to 1.00), but not hip fracture (0.95, 0.76 to 1.18) or forearm fracture (0.96, 0.85 to 1.09). Funnel plot inspection suggested publication bias favouring calcium. In the four trials at lowest risk of bias, covering 44,505 people, there was no effect on fracture at any site. Results were similar whether or not vitamin D was co-administered.
The Women's Health Initiative gives the same shape from a single large trial: calcium plus vitamin D raised hip bone density by 1.06% versus placebo, did not significantly reduce hip fracture (hazard ratio 0.88, 95% CI 0.72 to 1.08), and increased the risk of kidney stones (hazard ratio 1.17, 95% CI 1.02 to 1.34). Hip fracture reduction did become significant when analysis was censored at the point women stopped taking the tablets, which is a real signal about adherence and also a post hoc analysis.
What this does and does not mean
It does not mean calcium is bad for you. It means the pill and the plate are different interventions, and the pill's benefit-to-risk ratio in generally healthy people is much less favourable than the recommendation to take one suggests. The one trial in the fracture review that did show a clear reduction was in frail elderly women in residential care with low dietary calcium and low vitamin D — a population that was genuinely deficient.
That pattern should look familiar by now. Supplements do their best work in people with a shortfall, which is a good argument for finding out whether you have one before deciding whether you need supplements at all.
What we'd actually tell you
Count your dietary calcium first. Most people who assume they are short are not — dairy, fortified plant milks, tinned fish with bones, tofu set with calcium, and leafy greens add up faster than expected.
If you and your clinician decide a supplement is warranted, ask about the smallest dose that closes the gap rather than a standard 1,000mg tablet on top of a diet already supplying 800mg. Split doses are absorbed better than one large one. Keep it away from iron, which it blocks, and be aware that this is one of the mineral pairs on the list of interactions with medication.
On the K2 with D3 add-on marketed as the fix for all of this: the mechanism is coherent and the outcome trials have not delivered. It is not a licence to take calcium you did not need.
And if you have osteoporosis or a fracture history, none of the above is your protocol. That is a treatment decision with real drugs behind it, and it belongs with the clinician managing it.
Good questions
Are calcium supplements bad for your heart?
The evidence is concerning rather than conclusive. A meta-analysis of randomised trials found a hazard ratio of 1.31 for myocardial infarction with calcium supplements taken without vitamin D, and an observational cohort found supplement use associated with a 22% higher risk of developing coronary artery calcification even after adjusting for total intake. Dietary calcium showed the opposite association.
Do calcium supplements actually prevent fractures?
Weakly and inconsistently. Across 26 randomised trials they reduced total fracture risk by about 11%, with no significant effect on hip or forearm fracture. In the four trials at lowest risk of bias, covering 44,505 people, there was no effect at any site. The clear exception was frail elderly women in residential care with genuinely low intake.
How much calcium do I actually get from food?
More than most people estimate. Dairy, fortified plant milks, tinned fish with edible bones, calcium-set tofu and leafy greens add up quickly, and many adults are already close to the recommended intake without a tablet. Counting a typical week of eating before buying a supplement is the single most useful step here.
Should I stop my calcium supplement?
Not on the basis of an article. If it was recommended for osteoporosis, a fracture history, or a documented low intake, that recommendation was made about you and this is not. What is worth doing is taking the actual dose to your clinician and asking whether your diet has changed since it was prescribed, and whether a smaller dose would close the gap.
Do calcium supplements cause kidney stones?
They increased the risk in the largest randomised trial. In the Women's Health Initiative, calcium plus vitamin D raised the risk of kidney stones with a hazard ratio of 1.17 (95% CI 1.02 to 1.34). Dietary calcium does not carry the same association, which is another instance of the pill and the plate behaving differently.
Does taking vitamin K2 make calcium supplements safer?
There is no outcome evidence that it does. The mechanism, in which K2 activates proteins that inhibit arterial calcification, is real. The trials testing whether that translates into less calcification or fewer events have largely come back null. Taking K2 as a permission slip for calcium you did not need is not supported.
Sources
- Anderson JJ, Kruszka B, Delaney JA, et al. Calcium Intake From Diet and Supplements and the Risk of Coronary Artery Calcification and its Progression Among Older Adults: 10-Year Follow-up of the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Heart Assoc, 2016. View study
- Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ, 2010. View study
- Bolland MJ, Leung W, Tai V, et al. Calcium intake and risk of fracture: systematic review. BMJ, 2015. View study
- Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med, 2006. View study
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
